
Acute Myelogenous Leukemia
Kurzinformation



inkl. MwSt. Versandinformationen
Artikel zZt. nicht lieferbar
Artikel zZt. nicht lieferbar

Beschreibung
Acute myelogenous leukemia (AML), is the most common form of leukemia in adults. AML is a deadly form of malignancy, the prognosis for which has not improved in the last two decades. More importantly, it is a malignancy that is seen in older adults, therefore the number of cases is likely to rise as the population ages. Over the past 15 years, genetic mechanisms underlying AML have begun to unfold. Additional research in this area has helped identify key components and characteristics. Consequently, targeted therapy of AML is receiving much attention. It is the hope of researchers that as with chronic myelogenous leukemia (CML), and the drug, Gleevec, a targeted therapy for AML will be discovered. von Nagarajan, Lalitha
Produktdetails

So garantieren wir Dir zu jeder Zeit Premiumqualität.
Über den Autor
Lalitha Nagarajan is an Associate Professor, Department of Molecular Genetics, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas.
- Hardcover
- 704 Seiten
- Erschienen 1993
- Crc Pr Inc
- Hardcover
- 568 Seiten
- Erschienen 2016
- Wiley-Blackwell
- Hardcover
- 386 Seiten
- Erschienen 2002
- Greenwich Medical Media
- hardcover
- 580 Seiten
- Erschienen 2005
- Wiley-VCH
- paperback
- 496 Seiten
- Erschienen 1985
- MIT Press
- Hardcover -
- Erschienen 2005
- Nikol
- Hardcover
- 332 Seiten
- Erschienen 1997
- Humana
- Gebunden
- 284 Seiten
- Erschienen 2005
- Wiley-VCH
- hardcover
- 368 Seiten
- Erschienen 2011
- Poppy
- Gebunden
- 356 Seiten
- Erschienen 2013
- Springer